Treatment of excessive mediastinal bleeding after cardiopulmonary bypass

Annals of Thoracic Surgery

Volumn 62, Issue 6, 1996, Pages 1951-1954

  Hartstein, Gary ^a   Janssens, Marc ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; DESMOPRESSIN; PROTAMINE; THROMBOCYTE CONCENTRATE;

BLEEDING; CARDIOPULMONARY BYPASS; HUMAN; MEDIASTINUM; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW;

EID: 0030560596     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(96)00937-X     Document Type: Article

References (31)

1. 1. Czer LSC, Bateman TM, Gray RJ, et al. Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: reduction in blood product usage with desmopressin. J Am Coll Cardiol 1987;9:1139-47.
2. 2. Michelson EL, Torosian M, Morganroth J, MacVaugh H III. Early recognition of surgically correctable causes of excessive mediastinal bleeding after coronary artery bypass graft surgery. Am J Surg 1980;139:313-7.
3. 3. Verska JJ, Lonser ER, Brewer LA III. Predisposing factors and management of hemorrhage following open heart surgery. J Cardiovasc Surg 1972;13:361-8.
4. 4. Czer LSC. Mediastinal bleeding after cardiac surgery: etiologies, diagnostic considerations, and blood conservation methods. J Cardiothorac Anesth 1989;3:760-75.
5. 5. Mammen EF, Koets MH, Washington BC, et al. Hemostasis changes during cardiopulmonary bypass surgery. Semin Thromb Hemost 1985;11:281-92.
6. 6. Murphy WG, Davies MJ, Eduardo A. The haemostatic response to surgery and trauma. Br J Anaesth 1993;70:205-13.
7. 7. John LCH, Rees GM, Kovacs IB. Inhibition of platelet function by heparin. An etiologic factor in postbypass hemorrhage. J Thorac Cardiovasc Surg 1993;105:816-22.
8. 8. King DJ, Kelton JG. Heparin-associated thrombocytopenia. Ann Intern Med 1984;100:535-40.
9. 9. Harker LA, Malpass TW, Branson HE, Hessel EA III, Slichter SJ. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective α-granule release. Blood 1980;56:824-34.
10. 10. Uehlinger J, Adedort LM. Blood product usage in cardiac surgery. J Cardiothorac Anesth 1989;3:776-84.
11. 11. Ray MJ, Hawson GAT, Just SJE, McLachlan G, O'Brien M. Relationship of platelet aggregation to bleeding after cardiopulmonary bypass. Ann Thorac Surg 1994;57:981-6.
12. 12. Essell JH, Martin TJ, Salinas J, Thompson JM, Smith VC. Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1993;7:410-5.
13. 13. Spiess BD, Tuman KJ, McCarthy RJ, DeLaria GA, Schillo R, Ivankovich AD. Thromboelastography as an indicator of post-cardiopulmonary bypass coagulopathies. J Clini Monit 1987;3:25-30.
14. 14. Spiess BD. Thromboelastogram and postoperative hemorrhage. Ann Thorac Surg 1992;54:810-3.
15. 15. Wang JS, Lin CY, Hung WT, et al. Thromboelastogram fails to predict postoperative hemorrhage in cardiac patients. Ann Thorac Surg 1992;53:435-9.
16. 16. Lisi G, Sani G, Maccherini M, Biagioli B, Toscano M. Platelet function and hypothermic cardiopulmonary bypass. Ann Thorac Surg 1993;56:1442-3.
17. 17. Khuri SF, Wolfe JA, Josa M, et al. Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss. J Thorac Cardiovasc Surg 1992;104:94-107.
18. 18. Gray RJ, Bateman TM, Czer LSC, Conklin C, Matloff JM. Use of esmolol in hypertension after cardiac surgery. Am J Cardiol 1985;56:49F-56F.
19. 19. Ilabaca PA, Ochsner JL, Mills NL. Positive end-expiratory pressure in the management of the patient with a postoperative bleeding heart. Ann Thorac Surg 1980;30:281-4.
20. 20. Zurick AM, Urzua J, Ghattas M, Cosgrove DM, Estafanous FG, Greenstreet R. Failure of positive end-expiratory pressure to decrease postoperative bleeding after cardiac surgery. Ann Thorac Surg 1982;34:608-11.
21. 21. Huyzen RJ, Harder MP, Huet RC, Boonstra PW, Brenken U, van Oeveren W. Alternative perioperative anticoagulation monitoring during cardiopulmonary bypass in aprotinin-treated patients. J Cardiothorac Vasc Anesth 1994;8:153-6.
22. 22. Tice DA, Worth MHJ. Recognition and treatment of postoperative bleeding associated with open-heart surgery. Ann N Y Acad Sci 1968;146:745-53.
23. 23. Rodgers RPC, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost 1990;16:1-20.
24. 24. Dilthey G, Dietrich W, Spannagl M, Richter JA. Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. J Cardiothorac Vasc Anesth 1993;7:425-30.
25. 25. Sloand EM, Alyono D, Klein HG, et al. 1-Deamino-8-D-Arginine Vasopressin (DDAVP) increases platelet membrane expression of glycoprotein Ib in patients with disorders of platelet function and after cardiopulmonary bypass. Am J Hematol 1994;46:199-207.
26. 26. Fuhrer G, Gallimore MJ, Heller W, Hoffmeister HE. Aprotinin in cardiopulmonary bypass - effects on the Hageman factor (FXII)-kallikrein system and blood loss. Blood Coagul Fibrinolysis 1992;3:99-104.
27. 27. Tanaka K, Takao M, Yada I, Yuasa H, Kusagawa M, Deguchi K. Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery. J Cardiothorac Anesth 1989;3:181-8.
28. 28. Angelini GD, Cooper GJ, Lamarra M, Bryan AJ. Unorthodox use of aprotinin to control life-threatening bleeding after cardiopulmonary bypass. Lancet 1990;335:799-800.
29. 29. Çiçek S, Demirkiliç U, Kuralay E, Özal E, Tatar H. Postoperative aprotinin: effect on blood loss and transfusion requirements in cardiac operations. Ann Thorac Surg 1996;61: 1372-6.
30. 30. Van Oeveren W, Harder MP, Roozendaal KJ, Eijsman L, Wildevuur CRH. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990;99:788-97.
31. 31. Consensus conference. Fresh frozen plasma. Indications and risks. JAMA 1985;253:551-3.